Itraconazole Oral Solution

FDA identified interpretive criteria:

	Minimum Inhibitory Concentrations (mcg/mL)			Disk Diffusion (zone diameters in mm)
Pathogen	S	I	R	S	I	R
Candida albicansa	≤ 0.125	0.25 – 0.5	> 1	-	-	-

S = Susceptible; I = Intermediate; R = Resistant
^a Mucosal isolates only